This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
PET sheets are widely recognised for their superior clarity, strength, and barrier properties
The deal reinforces GSK’s leadership in respiratory care and builds upon the company’s expanding COPD portfolio
The event will be attended by 35,000+ industry professionals
The company’s “greener” initiatives emphasize eco-friendly excipients and energy-efficient manufacturing processes that reduce environmental impact without compromising product quality
This new facility strengthens Latin America as a collaborative hub
Subscribe To Our Newsletter & Stay Updated
